Tectonic Therapeutic, Inc. TECX

23.67 (0.45) (1.87%) as of 25 Sep
Market cap
$471.5M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Current Ratio

+8 more quarters

29.15 26.63 18.51 22.29
Net Debt/EBITDA
12.48 12.01 8.77 9.49
Debt/Assets
0.04% 0.02% 0.01% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00
Operating CF/Net income
0.94 0.75 0.73 0.96
Capex/Depreciation
(0.49) 0.00 (0.06) (0.21)
Interest Coverage
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
(0.96) (0.79) (0.98) (1.13)
Cash per Share
14.38 13.88 12.62 11.97
Shareholders Equity per Share
14.30 13.72 12.28 11.80
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
14.30 13.72 12.28 11.80
Free Cash Flow
(17.98) (14.46) (18.43) (21.51)
Working Capital
263.87 247.69 226.93 220.73
Capital Expenditures
(0.17) 0.00 (0.02) (0.06)
Net Current Asset Value
263.77 247.65 223.73 217.91
Other line items
Quick Ratio
28.70 26.32 18.28 21.90
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(0.95) (0.79) (0.98) (1.13)
Capex per Share
(0.01) 0.00 0.00 0.00
Average Payables
2.06 1.03 4.40 2.24
Average Assets
222.86 206.97 280.70 266.17
Average Common Equity
208.94 196.05 265.73 253.81
Capex to Sales
0.00 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates